Is Banner Display?
Off
Page Content
#ffffff
Video
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Thumbnail
d2h s1
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description

Speaker Name: Prof. Nikolaus Marx, Professor of Medicine/Cardiology, Head of Department, Internal Medicine, University Hospital, Aachen, Germany.

Explore this expert session to:

  • Understand the expanding role of SGLT2i in reducing CV events and HF hospitalization in patients with T2DM and high CV risk.
  • Review landmark trial evidence supporting SGLT2i use across HFrEF, HFmrEF, and HFpEF, irrespective of diabetes status.
  • Evaluate kidney-protective benefits of SGLT2i, including delayed CKD progression and reduced cardiorenal outcomes across broad eGFR ranges.
  • Interpret evidence supporting early in-hospital initiation of SGLT2i during ADHF admissions.
  • Apply current ESC and KDIGO recommendations for patient selection, initiation thresholds, and practical safety monitoring with SGLT2i therapy.
Release Date
Is Paid
0
Send Notification
Off
Most watched content
Off
Most watched content Order
0